Advances in Antimicrobial Strategies to Control Listeria in Food and Clinical Settings

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: 15 August 2025 | Viewed by 658

Special Issue Editor


E-Mail Website
Guest Editor
Research Group on Foods, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, Santander, Spain
Interests: food microbiology; foodborne pathogens; biofilms; cellular microbiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Listeria monocytogenes is a significant foodborne pathogen known for its resilience in diverse environments and its ability to cause severe illness, particularly in immunocompromised individuals, pregnant women, and the elderly. L. monocytogenes is frequently found in ready-to-eat foods, dairy products, and processed meats. Contamination of these foods can lead to outbreaks of listeriosis, a serious infection that can result in severe health complications and even death. This Special Issue will explore the latest innovations in antimicrobial approaches to manage and mitigate the risks associated with this persistent pathogen.

This Special Issue will cover a wide array of topics, including but not limited to the following:

  • Natural and synthetic antimicrobial agents: Discoveries and applications of novel agents effective against Listeria. Examples include the use of bacteriophages, essential oils, and bacteriocins.
  • Development and utilization of probiotic strains: Investigations into probiotic strains that can effectively prevent, inhibit, or reduce monocytogenes.
  • Biofilms in Listeria and anti-biofilm strategies: Exploring the formation of biofilms by Listeria and innovative approaches to disrupt and prevent biofilm formation, including the use of new materials such as advanced polymer coatings and enzymatic treatments.
  • Mechanisms of resistance: Understanding how Listeria develops resistance to current antimicrobials and exploring strategies to overcome these mechanisms.
  • Regulatory and safety considerations: Evaluating the safety and regulatory aspects of implementing new antimicrobial strategies in food production and healthcare settings.

Dr. José Ramos Vivas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Listeria monocytogenes
  • antimicrobial agents
  • biofilms
  • probiotic strains
  • mechanisms of resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

18 pages, 9659 KiB  
Article
Whole Genome Analysis of Pediococcus acidilactici XJ-24 and Its Role in Preventing Listeria monocytogenes ATCC® 19115TM Infection in C57BL/6 Mice
by Weizhong Hu, Shuxin Zhou, Amel Ibrahim, Guannan Li, Sameh Awad, José Ramos-Vivas, Jianquan Kan and Muying Du
Antibiotics 2025, 14(3), 323; https://doi.org/10.3390/antibiotics14030323 - 19 Mar 2025
Viewed by 504
Abstract
Background/Objectives: As probiotics gain prominence in the prevention and treatment of intestinal diseases, their protective effects against pathogens and influence on host health have drawn significant attention. This study investigates the genomic characteristics and functional potential of Pediococcus acidilactici XJ-24 (XJ-24) in the [...] Read more.
Background/Objectives: As probiotics gain prominence in the prevention and treatment of intestinal diseases, their protective effects against pathogens and influence on host health have drawn significant attention. This study investigates the genomic characteristics and functional potential of Pediococcus acidilactici XJ-24 (XJ-24) in the prevention of Listeria monocytogenes (LM) infection in mice. Methods/Results: Whole-genome analysis confirmed the safety and probiotic properties of XJ-24, including acid and bile salt tolerance, antimicrobial activity, and safety. In vivo, C57BL/6 mice challenges indicated that XJ-24 significantly reduced LM colonization, suppressed pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, IFN-γ), alleviated colon and spleen tissue damage, and maintained intestinal barrier integrity by upregulating tight junction proteins (Occludin, Claudin-1, ZO-1). Moreover, XJ-24 modulated gut microbiota composition by increasing beneficial taxa while reducing harmful bacteria. Correlation analysis highlighted a positive association between Lachnospiraceae and tight junction proteins. Conclusions: These findings demonstrate the potential of XJ-24 as a functional probiotic for preventing LM infection and provide a basis for further clinical exploration. Full article
Show Figures

Figure 1

Back to TopTop